Request for Covid-19 Impact Assessment of this Report
Production, means the output of Genitourinary Drugs
Revenue, means the sales value of Genitourinary Drugs
This report studies Genitourinary Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Teva Pharmaceutical
Taj Pharmaceuticals
Guangzhou Hanfang Pharmaceutical
Guangxi Hefeng Pharmaceutical
...
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Genitourinary Drugs in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Sex Hormones
Urologicals
Genitourinary Anti-Infectives
Gynaecologicals
Split by application, this report focuses on consumption, market share and growth rate of Genitourinary Drugs in each application, can be divided into
Genitourinary Cancer
Bladder Cancer
Cervical Cancer
Kidney/Renal Cancer
Ovarian Cancer
Prostate Cancer
Global Genitourinary Drugs Market Research Report 2016
1 Genitourinary Drugs Market Overview
1.1 Product Overview and Scope of Genitourinary Drugs
1.2 Genitourinary Drugs Segment by Type
1.2.1 Global Production Market Share of Genitourinary Drugs by Type in 2015
1.2.2 Sex Hormones
1.2.3 Urologicals
1.2.4 Genitourinary Anti-Infectives
1.2.5 Gynaecologicals
1.3 Genitourinary Drugs Segment by Application
1.3.1 Genitourinary Drugs Consumption Market Share by Application in 2015
1.3.2 Genitourinary Cancer
1.3.3 Bladder Cancer
1.3.4 Cervical Cancer
1.3.5 Kidney/Renal Cancer
1.3.6 Ovarian Cancer
1.3.7 Prostate Cancer
1.4 Genitourinary Drugs Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Genitourinary Drugs (2011-2021)
2 Global Genitourinary Drugs Market Competition by Manufacturers
2.1 Global Genitourinary Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Genitourinary Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Genitourinary Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Genitourinary Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Genitourinary Drugs Market Competitive Situation and Trends
2.5.1 Genitourinary Drugs Market Concentration Rate
2.5.2 Genitourinary Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Genitourinary Drugs Production, Revenue (Value) by Region (2011-2016)
3.1 Global Genitourinary Drugs Production and Market Share by Region (2011-2016)
3.2 Global Genitourinary Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Genitourinary Drugs Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Genitourinary Drugs Consumption by Regions (2011-2016)
4.2 North America Genitourinary Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Genitourinary Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Genitourinary Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Genitourinary Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Genitourinary Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Genitourinary Drugs Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Genitourinary Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Genitourinary Drugs Production and Market Share by Type (2011-2016)
5.2 Global Genitourinary Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Genitourinary Drugs Price by Type (2011-2016)
5.4 Global Genitourinary Drugs Production Growth by Type (2011-2016)
6 Global Genitourinary Drugs Market Analysis by Application
6.1 Global Genitourinary Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Genitourinary Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Genitourinary Drugs Manufacturers Profiles/Analysis
7.1 Teva Pharmaceutical
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Genitourinary Drugs Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Teva Pharmaceutical Genitourinary Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Taj Pharmaceuticals
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Genitourinary Drugs Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Taj Pharmaceuticals Genitourinary Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Guangzhou Hanfang Pharmaceutical
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Genitourinary Drugs Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Guangzhou Hanfang Pharmaceutical Genitourinary Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Guangxi Hefeng Pharmaceutical
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Genitourinary Drugs Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Guangxi Hefeng Pharmaceutical Genitourinary Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
...
8 Genitourinary Drugs Manufacturing Cost Analysis
8.1 Genitourinary Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Genitourinary Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Genitourinary Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Genitourinary Drugs Market Forecast (2016-2021)
12.1 Global Genitourinary Drugs Production, Revenue Forecast (2016-2021)
12.2 Global Genitourinary Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Genitourinary Drugs Production Forecast by Type (2016-2021)
12.4 Global Genitourinary Drugs Consumption Forecast by Application (2016-2021)
12.5 Genitourinary Drugs Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Genitourinary Drugs
Figure Global Production Market Share of Genitourinary Drugs by Type in 2015
Figure Product Picture of Sex Hormones
Table Major Manufacturers of Sex Hormones
Figure Product Picture of Urologicals
Table Major Manufacturers of Urologicals
Figure Product Picture of Genitourinary Anti-Infectives
Table Major Manufacturers of Genitourinary Anti-Infectives
Figure Product Picture of Gynaecologicals
Table Major Manufacturers of Gynaecologicals
Table Genitourinary Drugs Consumption Market Share by Application in 2015
Figure Genitourinary Cancer Examples
Figure Bladder Cancer Examples
Figure Cervical Cancer Examples
Figure Kidney/Renal Cancer Examples
Figure Ovarian Cancer Examples
Figure Prostate Cancer Examples
Figure North America Genitourinary Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Genitourinary Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Genitourinary Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Genitourinary Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Genitourinary Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Genitourinary Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Genitourinary Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Genitourinary Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Genitourinary Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Genitourinary Drugs Production Share by Manufacturers
Figure 2016 Genitourinary Drugs Production Share by Manufacturers
Table Global Genitourinary Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Genitourinary Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Genitourinary Drugs Revenue Share by Manufacturers
Table 2016 Global Genitourinary Drugs Revenue Share by Manufacturers
Table Global Market Genitourinary Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Genitourinary Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Genitourinary Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Genitourinary Drugs Product Type
Figure Genitourinary Drugs Market Share of Top 3 Manufacturers
Figure Genitourinary Drugs Market Share of Top 5 Manufacturers
Table Global Genitourinary Drugs Production by Regions (2011-2016)
Figure Global Genitourinary Drugs Production and Market Share by Regions (2011-2016)
Figure Global Genitourinary Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Genitourinary Drugs Production Market Share by Regions
Table Global Genitourinary Drugs Revenue by Regions (2011-2016)
Table Global Genitourinary Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Genitourinary Drugs Revenue Market Share by Regions
Table Global Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Genitourinary Drugs Consumption Market by Regions (2011-2016)
Table Global Genitourinary Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Genitourinary Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Genitourinary Drugs Consumption Market Share by Regions
Table North America Genitourinary Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Genitourinary Drugs Production, Consumption, Import & Export (2011-2016)
Table China Genitourinary Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Genitourinary Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Genitourinary Drugs Production, Consumption, Import & Export (2011-2016)
Table India Genitourinary Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Genitourinary Drugs Production by Type (2011-2016)
Table Global Genitourinary Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Genitourinary Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Genitourinary Drugs by Type
Table Global Genitourinary Drugs Revenue by Type (2011-2016)
Table Global Genitourinary Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Genitourinary Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Genitourinary Drugs by Type
Table Global Genitourinary Drugs Price by Type (2011-2016)
Figure Global Genitourinary Drugs Production Growth by Type (2011-2016)
Table Global Genitourinary Drugs Consumption by Application (2011-2016)
Table Global Genitourinary Drugs Consumption Market Share by Application (2011-2016)
Figure Global Genitourinary Drugs Consumption Market Share by Application in 2015
Table Global Genitourinary Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Genitourinary Drugs Consumption Growth Rate by Application (2011-2016)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Genitourinary Drugs Market Share (2011-2016)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Taj Pharmaceuticals Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Taj Pharmaceuticals Genitourinary Drugs Market Share (2011-2016)
Table Guangzhou Hanfang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Guangzhou Hanfang Pharmaceutical Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Guangzhou Hanfang Pharmaceutical Genitourinary Drugs Market Share (2011-2016)
Table Guangxi Hefeng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Guangxi Hefeng Pharmaceutical Genitourinary Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Guangxi Hefeng Pharmaceutical Genitourinary Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genitourinary Drugs
Figure Manufacturing Process Analysis of Genitourinary Drugs
Figure Genitourinary Drugs Industrial Chain Analysis
Table Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
Table Major Buyers of Genitourinary Drugs
Table Distributors/Traders List
Figure Global Genitourinary Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Genitourinary Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Genitourinary Drugs Production Forecast by Regions (2016-2021)
Table Global Genitourinary Drugs Consumption Forecast by Regions (2016-2021)
Table Global Genitourinary Drugs Production Forecast by Type (2016-2021)
Table Global Genitourinary Drugs Consumption Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...